4.8 Article

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

Journal

IMMUNITY
Volume 21, Issue 4, Pages 589-601

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2004.09.002

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [AI 37618] Funding Source: Medline
  2. NICHD NIH HHS [5T32 HD 43010] Funding Source: Medline
  3. NIDDK NIH HHS [DK 49786] Funding Source: Medline

Ask authors/readers for more resources

Cytotoxic T lymphocytes and natural killer cells use the perforin/granzyme pathway to kill virally infected cells and tumor cells. Mutations in genes important for this pathway are associated with several human diseases. CD4(+) T regulatory (Treg) cells have emerged as important in the control of immunopathological processes. We have previously shown that human adaptive Treg cells preferentially express granzyme B and can kill allogeneic target cells in a perforin-dependent manner. Here, we demonstrate that activated human CD4(+)CD25(+) natural Treg cells express granzyme A but very little granzyme B. Furthermore, both Treg sub-types display perforin-dependent cytotoxicity against autologous target cells, including activated CD4(+) and CD8(+) T cells, CD14(+) monocytes, and both immature and mature dendritic cells. This cytotoxicity is dependent on CD18 adhesive interactions but is independent of Fas/FasL. Our findings suggest that the perforin/granzyme pathway is one of the mechanisms that Treg cells can use to control immune responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available